Improving selectivity and sensitivity of lipid mediator analyses by coupling nano-flow chromatography with the Stellar mass spectrometer

Importance of the Topic

Signaling lipids regulate key biological processes, including inflammation resolution and restoration of tissue homeostasis. Quantifying these mediators at trace concentrations in complex biological matrices is essential for advancing disease research, therapeutic development, and rigorous quality control in analytical laboratories.

Goals and Study Overview

This work evaluates a targeted lipid mediator analysis workflow that combines nano-flow ultra-high-performance liquid chromatography (UHPLC) with a Thermo Scientific Stellar mass spectrometer. The performance of this nano-flow approach is benchmarked against a conventional high-flow UHPLC–triple quadrupole MS method, focusing on sensitivity, selectivity, and analytical throughput.

Methodology

Lipid mediator standards were prepared with stable isotope-labeled internal references and calibration curves spanning low-ppt to ppb levels. Two chromatographic regimes were compared:

• Nano-flow UHPLC at 500 nL/min using a PepMap Neo column.
• High-flow UHPLC at 300 µL/min using a Hypersil Gold column.

Parallel reaction monitoring (PRM) with both HCD and CID fragmentation was performed on the Stellar mass spectrometer, while selected reaction monitoring (SRM/MRM) was used on a TSQ Altis Plus triple quadrupole MS. Data processing and quantitation employed Thermo Scientific TraceFinder software.

Used Instrumentation

• Thermo Scientific Vanquish Neo UHPLC (nano-flow)
• Thermo Scientific Vanquish Horizon UHPLC (high-flow)
• Thermo Scientific Stellar mass spectrometer (dual-pressure linear ion trap, HCD and CID)
• Thermo Scientific TSQ Altis Plus triple quadrupole mass spectrometer

Main Results and Discussion

The nano-flow Stellar workflow achieved limits of quantitation in the low picogram to sub-ppt range, outperforming the high-flow methods by approximately 5–10-fold lower detection limits. Key findings include:

• PRM captured more than ten scans across each chromatographic peak, enhancing quantitation precision.
• Prostaglandin E₂ calibration was linear from 10 fg to 100 pg on-column in nano-flow mode.
• Combined HCD and CID fragmentation provided richer spectral data for confident identification of structurally similar lipids.

Benefits and Practical Applications

• Enhanced sensitivity enables reliable detection of low-abundance mediators in limited sample volumes.
• PRM simplifies method development by monitoring multiple transitions simultaneously.
• Reduced solvent consumption and shorter run times support high-throughput lipidomics analyses.
• Improved selectivity minimizes false positives in complex biological matrices.

Future Trends and Opportunities

Ongoing advances are expected to further elevate lipid mediator profiling capabilities:

• Microfluidic integration for automated sample handling and reduced dead volume.
• Expanded MSⁿ fragmentation schemes for in-depth structural elucidation of novel lipids.
• Machine learning–driven optimization of PRM transitions and data processing workflows.
• Translation of ultra-sensitive lipidomics to clinical diagnostics for inflammation-related diseases.

Conclusion

The nano-flow UHPLC–Stellar MS workflow demonstrates a significant leap in sensitivity, selectivity, and throughput for targeted lipid mediator analysis. By harnessing PRM with dual fragmentation modes and minimizing solvent usage, this approach surpasses traditional high-flow triple quadrupole methods, offering a powerful platform for research and quality control in lipidomics.